Xtant Medical Holdings, Inc. (NYSEAM:XTNT) acquired Coflex and Cofix Product Lines of Surgalign Holdings, Inc. (NasdaqGS:SRGA) for $17 million on February 28, 2023. The purchase price was funded with cash on hand and approximately $5 million was financed by MidCap Financial Trust under its Credit, Security and Guarantee Agreement (Term Loan). In relation with this transaction Xtant Medical entered into Credit, security and guaranty agreement with MidCap Financial Trust to partially fund the transaction. Subsequent to the Transaction, the to Surgalign Holdings, Inc changed its name to Surgalign Spine Technologies. UBS Investment Bank served as exclusive financial advisor and Larry Nishnick of DLA Piper LLP served as legal counsel to Surgalign and Thomas Letscher of Fox Rothschild LLP served as legal counsel to Xtant in connection with this transaction.

Xtant Medical Holdings, Inc. (NYSEAM:XTNT) completed the acquisition of Coflex and Cofix Product Lines of Surgalign Holdings, Inc. (NasdaqGS:SRGA) on February 28, 2023.